Yellowbird Diagnostics Announces First Patients Dosed in Phase 1 Trial of NeuCavis(TM)
Yellowbird Diagnostics Inc. today announced the successful dosing and imaging of the first participants in its Phase I clinical trial of NeuCaVis™, a novel metabolic PET imaging agent designed to…